POZ - Latino Hub : Treatment News : ARV Treatment Eases Cape Town TB Rates - by Tim Horn

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

July 22, 2009

ARV Treatment Eases Cape Town TB Rates

by Tim Horn

Wider use of antiretroviral (ARV) therapy during the past three years has significantly reduced the rate of tuberculosis (TB). This encouraging news was reported Wednesday, July 22, at the Fifth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town.

The HIV epidemic is driving TB epidemics to alarming rates in sub-Saharan Africa, said lead study author Keren Middelkoop, MD, of the Desmond Tutu HIV Centre at the University of Cape Town. Though it has been suggested that more widespread use will reduce the incidence and prevalence of TB, few data are available to confirm this hypothesis.

In 2005, Middelkoop’s group documented a high rate of undiagnosed TB before large-scale ARV availability, in a community with high HIV prevalence. In this analysis, HIV-positive individuals had a higher proportion of undiagnosed TB compared with HIV-negative individuals.

Middelkoop’s presentation at IAS focused on a 2008 follow-up survey, using similar methodology to the 2005 study. A random population was enrolled in the study, with each individual providing a completed survey and two phlegm samples for Mycobacterium tuberculosis testing. Rapid oral HIV testing was also conducted.

The average age of the 1,259 participants was 29 years. About 50 percent were female, and the HIV prevalence rate was 25 percent. Thirty-one percent of those living with HIV enrolled in the study were receiving ARV therapy.

The analysis reported by Middlekoop compared 310 HIV-positive individuals evaluated in the 2008 study with 175 in the 2005 study. It also compared 949 HIV-negative individuals from the 2008 study with 584 HIV-negative individuals from the 2005 study.

In 2005, about 4 percent of the HIV-positive volunteers were on treatment for tuberculosis and 5.2 percent had undiagnosed and untreated TB. In 2008, these rates dropped to 1.3 and 1.6 percent, respectively. Overall, Middelkoop reported, the tuberculosis rate among HIV-positive individuals dropped from 9.2 percent in 2005 to 2.9 percent in 2008—a statistically significant finding.

Rates among HIV-negative individuals remained fairly constant and, in fact, may have risen slightly. Overall, the tuberculosis rate was 1.2 percent in 2005 and 2.0 percent in 2008 among those uninfected with HIV. This difference, however, was not statistically significant.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.